Prostate Cancer

Dr. Plourde is a senior clinic evaluator for the Health Canada’s regulatory agency. He is an associate professor in the department of clinical pharmacology and physiology, Faculty of Medicine at the University of Montreal and at the school of physical activity sciences, Faculty of Health Sciences at the University of Ottawa. He holds a doctorate in medicine (MD) from the University of Montreal and a PhD in experimental medicine from Laval University. His studies led him to publish several articles in highly rated peer-reviewed journals and to make numerous presentations for prestigious national and international associations. He has more than 12 years’ experience working on drug safety, especially for biologic products involved in the treatment of various cancers. He has also supervised many students and employees interested in the prevention of the adverse effects of health products both in clinical research and/or when health products have obtained marketing authorization.

Case report 1. Presentation of the case reportCase report 2. Other differential diagnosisCase report 3. Treatment optionsCase report 4. External Risk FactorsCase report 5. Paraneoplastic syndromeCase report 6. Bone metastasis and its treatmentCase report 7. How to improve quality of lifeCase report 8. Treatment modalities in developmentCase report 9. Biomarkers of prostate cancerCase report 10. Euthanasia or assisted suicide or palliative sedation